Citadel Advisors
RNXT icon

Citadel Advisors’s RenovoRx RNXT Stock Holding History

Citadel Advisors’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
133,597
-99,087
-43% -$90.1K ﹤0.01% 12468
2026
Q1 		$235K Buy
232,684
+179,276
+336% +$174K ﹤0.01% 11061
2025
Q4 		$44.9K Sell
53,408
-67,933
-56% -$68K ﹤0.01% 12077
2025
Q3 		$154K Buy
+121,341
New +$144K ﹤0.01% 11512
2025
Q1 		– Sell
-37,757
Closed -$48.7K – 15415
2024
Q4 		$48.7K Buy
+37,757
New +$43K ﹤0.01% 12419
2024
Q3 		– Sell
-26,195
Closed -$29.6K – 15086
2024
Q2 		$29.6K Buy
+26,195
New +$32.2K ﹤0.01% 12289
2021
Q4 		– Sell
-12,010
Closed -$73K – 14608
2021
Q3 		$73K Buy
+12,010
New +$100K ﹤0.01% 13130

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Citadel Advisors's RNXT Position: Q2 2026 in Review

Citadel Advisors reduced its RenovoRx (RNXT) stake by 43% in Q2 2026, selling an estimated $90.1K and leaving 133,597 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #12468.

Citadel Advisors first reported a position in RNXT in Q3 2021 and has held it in 7 quarters since. The position peaked at $235K in Q1 2026. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Citadel Advisors held 133,597 shares of RenovoRx worth $131K as of Q2 2026.
  • Citadel Advisors sold 99,087 RenovoRx shares in Q2 2026, an estimated $90.1K.
  • RenovoRx made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12468 holding.
  • Citadel Advisors first reported a position in RenovoRx in Q3 2021 and has held it in 7 quarters since.
  • Citadel Advisors's RenovoRx position peaked at $235K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.